Cross-over study of muzolimine and hydrochlorothiazide-amiloride in hypertensive patients (630 views visite)
Eur J Clin Pharmacol Springer Verlag (ISSN: 0031-6970, 1432-1041), 1985; 28(3): 241-244.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article,
Impact factor: 1.219, 5-year impact factor Impact factor a 5 anni: 2.258
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-0021884255&partnerID=40&md5=46d0365529b4b6e62e0d5c970c241b8b
Keywords Parole chiave: Antihypertensive Treatment, Hydrochlorothiazide + Amiloride, Hypertensive Patients, Muzolimine, Serum Potassium, Side-Effects, Hypertensive Agent, New Drug, Placebo, Adverse Drug Reaction, Blood Pressure, Cardiovascular System, Clinical Trial, Controlled Study, Drug Comparison, Drug Efficacy, Drug Therapy, Drug Tolerance, Human, Human Experiment, Methodology, Oral Drug Administration, Potassium Blood Level, Priority Journal, Adult, Drug Combinations, Female, Lipids, Middle Aged, Pyrazines, Pyrazoles,
Affiliations Affiliazioni:
Institute of Internal Medicine and Metabolic Diseases, 2nd Medical School, University of Naples, Italy
Medical Department, Bayer Italia S.p.A., Italy
References Riferimenti:
Not available. Non disponibili.
Eur J Clin Pharmacol Springer Verlag (ISSN: 0031-6970, 1432-1041), 1985; 28(3): 241-244.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article,
Impact factor: 1.219, 5-year impact factor Impact factor a 5 anni: 2.258
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-0021884255&partnerID=40&md5=46d0365529b4b6e62e0d5c970c241b8b
Keywords Parole chiave: Antihypertensive Treatment, Hydrochlorothiazide + Amiloride, Hypertensive Patients, Muzolimine, Serum Potassium, Side-Effects, Hypertensive Agent, New Drug, Placebo, Adverse Drug Reaction, Blood Pressure, Cardiovascular System, Clinical Trial, Controlled Study, Drug Comparison, Drug Efficacy, Drug Therapy, Drug Tolerance, Human, Human Experiment, Methodology, Oral Drug Administration, Potassium Blood Level, Priority Journal, Adult, Drug Combinations, Female, Lipids, Middle Aged, Pyrazines, Pyrazoles,
Affiliations Affiliazioni:
Institute of Internal Medicine and Metabolic Diseases, 2nd Medical School, University of Naples, Italy
Medical Department, Bayer Italia S.p.A., Italy
References Riferimenti:
Not available. Non disponibili.
Cross-over study of muzolimine and hydrochlorothiazide-amiloride in hypertensive patients
Thiazide therapy is a widely used first line treatment for arterial hypertension. Its useful value, particularly in mild or moderate hypertension, is sometimes reduced by metabolic side-effects, as hypokalaemia and hyperuricaemia. In the present study the antihypertensive efficacy of a new, non-sulphonamide diuretic Bay g 2821 (muzolimine) was evaluated in comparison with the combination of hydrochlorothiazide-amiloride over a period of 4 weeks. A highly significant decrease in systolic and diastolic blood pressures was produced by both treatments. No decrease in serum potassium nor an increase in cholesterol, triglycerides, uric acid or glucose was detected during the 4 week treatment period. Subjective side-effects, such as headache and dizziness, were very rarely observed during Bay g 2821 treatment. The new diuretic appears, therefore, to be effective in the treatment of arterial hypertension without untoward side-effects. © 1985 Springer-Verlag.
Thiazide therapy is a widely used first line treatment for arterial hypertension. Its useful value, particularly in mild or moderate hypertension, is sometimes reduced by metabolic side-effects, as hypokalaemia and hyperuricaemia. In the present study the antihypertensive efficacy of a new, non-sulphonamide diuretic Bay g 2821 (muzolimine) was evaluated in comparison with the combination of hydrochlorothiazide-amiloride over a period of 4 weeks. A highly significant decrease in systolic and diastolic blood pressures was produced by both treatments. No decrease in serum potassium nor an increase in cholesterol, triglycerides, uric acid or glucose was detected during the 4 week treatment period. Subjective side-effects, such as headache and dizziness, were very rarely observed during Bay g 2821 treatment. The new diuretic appears, therefore, to be effective in the treatment of arterial hypertension without untoward side-effects. © 1985 Springer-Verlag.
Cross-over study of muzolimine and hydrochlorothiazide-amiloride in hypertensive patients
| ▼ Carbonic Anhydrase family as target for rational drug design |
| ▼ Targeted Drug Delivery by integrin avb3 antagonist |
Cross-over study of muzolimine and hydrochlorothiazide-amiloride in hypertensive patients
Acampa W, Rozza F, Zampella E, Assante R, Mannarino T, Nappi C, Mainolfi C, Petretta M, Trimarco B, Cuocolo A
* Warranty period of normal stress myocardial perfusion imaging in hypertensive patients: A parametric survival analysis (9 visite)
J Nucl Cardiol (ISSN: 1071-3581linking), 2020 Apr; 27(2): 534-541.
Impact Factor: 3.847
Dettagli Esporta in BibTeX Esporta in EndNote
Acampa W, Rozza F, Zampella E, Assante R, Mannarino T, Nappi C, Mainolfi C, Petretta M, Trimarco B, Cuocolo A
* Warranty period of normal stress myocardial perfusion imaging in hypertensive patients: A parametric survival analysis (162 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2018 Apr; N/D: 1-8.
Impact Factor: 3.93
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, D'Avino V, Liuzzi R, Conson M, Doria F, Faiella A, Loffredo F, Salvatore M, Pacelli R
* Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer (310 visite)
Radiation Oncology (ISSN: 1748-717x), 2013 Sep 23; 8(1): 221-221.
Impact Factor: 2.36
Dettagli Esporta in BibTeX Esporta in EndNote
Gargiulo P, Petretta M, Bruzzese D, Cuocolo A, Prastaro M, D'Amore C, Vassallo E, Savarese G, Marciano C, Paolillo S, Filardi PP
* Myocardial perfusion scintigraphy and echocardiography for detecting coronary artery disease in hypertensive patients: a meta-analysis (240 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2011 Nov; 38(11): 2040-2049.
Impact Factor: 4.991
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, Nicolai E, Petretta M, Spinelli L, Acampa W, Evangelista L, Daniele S, Trimarco B, Cuocolo A
* Cardiac performance during exercise in hypertensive patients without ventricular hypertrophy (238 visite)
Eur J Clin Invest (ISSN: 0014-2972, 1365-2362), 2009 Sep; 39(8): 664-670.
Impact Factor: 2.643
Dettagli Esporta in BibTeX Esporta in EndNote
Iaccarino G, Izzo R, Trimarco V, Cipolletta E, Lanni F, Sorriento D, Iovino GL, Rozza F, De Luca N, Priante O, Di Renzo G, Trimarco B
* β 2-Adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension (289 visite)
Clin Pharmacol Ther Clinical Pharmacology And Therapeutics (ISSN: 0009-9236), 2006; 80(6): 633-645.
Impact Factor: 8.066
Dettagli Esporta in BibTeX Esporta in EndNote
Porcellini M, Mainenti PP, Bracale U
* Endograft repair of spontaneous infrarenal abdominal aortic dissection (137 visite)
Journal Of Vascular Surgery (ISSN: 0741-5214), 2005 Jan; 41(1): 155-155.
Impact Factor: 3.173
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Storto G, Izzo R, Iovino GL, Damiano M, Bertocchi F, Mann J, Trimarco B
Effects of valsartan on left ventricular diastolic function in patients with mild or moderate essential hypertension: Comparison with enalapril (218 visite)
Journal Of Hypertension (ISSN: 0263-6352), 1999 Dec; 17(12): 1759-1766.
Impact Factor: 3.039
Dettagli Esporta in BibTeX Esporta in EndNote
Ferrara LA, Iannuzzi R, Gaeta I, Mancini M, Guida L, Marotta T
Left ventricular hypertrophy and hypertension (310 visite)
Clin Exp Hypertens Informa Healthcare, 1996 Jul; 15(6): 1025-1032.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Marotta T, Ferrara LA, Di Marino L, Mancini M, Annuzzi G, Russo O, D'Orta G, Lucarelli C, Rossi F
Factors affecting lipoprotein lipase in hypertensive patients (277 visite)
Metab Clin Exp (ISSN: 0026-0495, 1532-8600), 1995 Jun; 44(6): 712-718.
Impact Factor: 1.681
Dettagli Esporta in BibTeX Esporta in EndNote
Ferrara LA, Mancini M, Iannuzzi R, Marotta T, Gaeta I, Pasanisi F, Postiglione A, Guida L
CAROTID DIAMETER AND BLOOD-FLOW VELOCITIES IN CEREBRAL-CIRCULATION IN HYPERTENSIVE PATIENTS (184 visite)
Stroke (ISSN: 0039-2499), 1995 Mar; 26(3): 418-421.
Impact Factor: 4.323
Dettagli Esporta in BibTeX Esporta in EndNote
Ferrara LA, Mancini M, Celentano A, Galderisi M, Iannuzzi R, Marotta T, Gaeta I
Early changes of the arterial carotid wall in uncomplicated primary hypertensive patients: Study by ultrasound high-resolution B-mode imaging (227 visite)
Arterioscler Thromb Vasc Biol Arteriosclerosis Thrombosis And Vascular Biology (ISSN: 1079-5642, 1049-8834), 1994 Sep; 14(8): 1290-1296.
Impact Factor: 5.317
Dettagli Esporta in BibTeX Esporta in EndNote
Mancini M, Iannuzzi R, Marotta T, Ferrara LA
Peripheral Haemodynamics In Hypertensive Patients (180 visite)
J Hum Hypertens, 1992 May; N/D: 39A-39A.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Ferrara LA, Mancini M, Soricelli A, Postiglione A, Iannuzzi A, Iannuzzi R
Regional Hemodynamics During Ketanserin Treatment In Hypertensive Patients (192 visite)
Fifth European Meeting On Hypertension European Society Of Hypertension Milan, 1991 Oct; N/D: 209-209.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Ferrara LA, Mancini Marcello, Soro S, Soricelli A, Postiglione A, Iannuzzi A, Iannuzzi R
Regional Haemodynamics During Ketanserin In Hypertensive Patients (209 visite)
Acta Therapeuthica, 1991; N/D: 229-238.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Ferrara La, Soro S, Marotta T, Pasanisi F, Mancini M, Fasano ML, Gaeta I
Age And Choice Of Antihypertensive Treatment (173 visite)
Atherosclerosis, 1989; 4(b): 851-861.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Esposito S, Volpe M, Celentano L, Brunetti A, Salvatore M
Renal artery stenosis detection by combined Gates' technique and captopril test in hypertensive patients (229 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1989; 30(1): 51-56.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Ferrara LA, Marotta T, Fasano ML, Pasanisi F, Mancini M, Soro S
Relationship Between Characteristics Of Patients And Changes In Blood Pressure During Antihypertensive Treatment (177 visite)
Third European Meeting On Hypertension Milan Italy, 1987; N/D: 168-168.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Mancini M, Pisanti N, Capone D, Fasano ML, Ferrara LA
Salt Intake And Sympathetic Responsiveness In Hypertensive Patients (181 visite)
International Symposium On Nutritional And Metabolic Aspect Of Arterial Hypertension Anacapri, 1985 Apr; N/D: N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Strazzullo P, Ferrara LA, Galletti F, Mancini M, Mastranzo P
Crossover Comparison Of The Antihypertensive And Metabolic Effects Of Muzolimine And The Combination Hydrochlorithiazide-Amiloride (200 visite)
Recent Advances In Diuretic Therapy Andreucci Ve Ed Excerpta Medica, 1983; N/D: 328-334.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Vai a fine pagina Versione per copia e incolla facile Esporta tutto in BibTeX Esporta tutto in EndNote
Acampa W, Rozza F, Zampella E, Assante R, Mannarino T, Nappi C, Mainolfi C, Petretta M, Trimarco B, Cuocolo A
* Warranty period of normal stress myocardial perfusion imaging in hypertensive patients: A parametric survival analysis (9 visite)
J Nucl Cardiol (ISSN: 1071-3581linking), 2020 Apr; 27(2): 534-541.
Impact Factor: 3.847
Dettagli Esporta in BibTeX Esporta in EndNote
Acampa W, Rozza F, Zampella E, Assante R, Mannarino T, Nappi C, Mainolfi C, Petretta M, Trimarco B, Cuocolo A
* Warranty period of normal stress myocardial perfusion imaging in hypertensive patients: A parametric survival analysis (162 visite)
J Nucl Cardiol (ISSN: 1071-3581, 1532-6551, 1532-6551electronic), 2018 Apr; N/D: 1-8.
Impact Factor: 3.93
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, D'Avino V, Liuzzi R, Conson M, Doria F, Faiella A, Loffredo F, Salvatore M, Pacelli R
* Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer (310 visite)
Radiation Oncology (ISSN: 1748-717x), 2013 Sep 23; 8(1): 221-221.
Impact Factor: 2.36
Dettagli Esporta in BibTeX Esporta in EndNote
Gargiulo P, Petretta M, Bruzzese D, Cuocolo A, Prastaro M, D'Amore C, Vassallo E, Savarese G, Marciano C, Paolillo S, Filardi PP
* Myocardial perfusion scintigraphy and echocardiography for detecting coronary artery disease in hypertensive patients: a meta-analysis (240 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2011 Nov; 38(11): 2040-2049.
Impact Factor: 4.991
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, Nicolai E, Petretta M, Spinelli L, Acampa W, Evangelista L, Daniele S, Trimarco B, Cuocolo A
* Cardiac performance during exercise in hypertensive patients without ventricular hypertrophy (238 visite)
Eur J Clin Invest (ISSN: 0014-2972, 1365-2362), 2009 Sep; 39(8): 664-670.
Impact Factor: 2.643
Dettagli Esporta in BibTeX Esporta in EndNote
Iaccarino G, Izzo R, Trimarco V, Cipolletta E, Lanni F, Sorriento D, Iovino GL, Rozza F, De Luca N, Priante O, Di Renzo G, Trimarco B
* β 2-Adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension (289 visite)
Clin Pharmacol Ther Clinical Pharmacology And Therapeutics (ISSN: 0009-9236), 2006; 80(6): 633-645.
Impact Factor: 8.066
Dettagli Esporta in BibTeX Esporta in EndNote
Porcellini M, Mainenti PP, Bracale U
* Endograft repair of spontaneous infrarenal abdominal aortic dissection (137 visite)
Journal Of Vascular Surgery (ISSN: 0741-5214), 2005 Jan; 41(1): 155-155.
Impact Factor: 3.173
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Storto G, Izzo R, Iovino GL, Damiano M, Bertocchi F, Mann J, Trimarco B
Effects of valsartan on left ventricular diastolic function in patients with mild or moderate essential hypertension: Comparison with enalapril (218 visite)
Journal Of Hypertension (ISSN: 0263-6352), 1999 Dec; 17(12): 1759-1766.
Impact Factor: 3.039
Dettagli Esporta in BibTeX Esporta in EndNote
Ferrara LA, Iannuzzi R, Gaeta I, Mancini M, Guida L, Marotta T
Left ventricular hypertrophy and hypertension (310 visite)
Clin Exp Hypertens Informa Healthcare, 1996 Jul; 15(6): 1025-1032.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Marotta T, Ferrara LA, Di Marino L, Mancini M, Annuzzi G, Russo O, D'Orta G, Lucarelli C, Rossi F
Factors affecting lipoprotein lipase in hypertensive patients (277 visite)
Metab Clin Exp (ISSN: 0026-0495, 1532-8600), 1995 Jun; 44(6): 712-718.
Impact Factor: 1.681
Dettagli Esporta in BibTeX Esporta in EndNote
Ferrara LA, Mancini M, Iannuzzi R, Marotta T, Gaeta I, Pasanisi F, Postiglione A, Guida L
CAROTID DIAMETER AND BLOOD-FLOW VELOCITIES IN CEREBRAL-CIRCULATION IN HYPERTENSIVE PATIENTS (184 visite)
Stroke (ISSN: 0039-2499), 1995 Mar; 26(3): 418-421.
Impact Factor: 4.323
Dettagli Esporta in BibTeX Esporta in EndNote
Ferrara LA, Mancini M, Celentano A, Galderisi M, Iannuzzi R, Marotta T, Gaeta I
Early changes of the arterial carotid wall in uncomplicated primary hypertensive patients: Study by ultrasound high-resolution B-mode imaging (227 visite)
Arterioscler Thromb Vasc Biol Arteriosclerosis Thrombosis And Vascular Biology (ISSN: 1079-5642, 1049-8834), 1994 Sep; 14(8): 1290-1296.
Impact Factor: 5.317
Dettagli Esporta in BibTeX Esporta in EndNote
Mancini M, Iannuzzi R, Marotta T, Ferrara LA
Peripheral Haemodynamics In Hypertensive Patients (180 visite)
J Hum Hypertens, 1992 May; N/D: 39A-39A.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Ferrara LA, Mancini M, Soricelli A, Postiglione A, Iannuzzi A, Iannuzzi R
Regional Hemodynamics During Ketanserin Treatment In Hypertensive Patients (192 visite)
Fifth European Meeting On Hypertension European Society Of Hypertension Milan, 1991 Oct; N/D: 209-209.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Ferrara LA, Mancini Marcello, Soro S, Soricelli A, Postiglione A, Iannuzzi A, Iannuzzi R
Regional Haemodynamics During Ketanserin In Hypertensive Patients (209 visite)
Acta Therapeuthica, 1991; N/D: 229-238.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Ferrara La, Soro S, Marotta T, Pasanisi F, Mancini M, Fasano ML, Gaeta I
Age And Choice Of Antihypertensive Treatment (173 visite)
Atherosclerosis, 1989; 4(b): 851-861.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Esposito S, Volpe M, Celentano L, Brunetti A, Salvatore M
Renal artery stenosis detection by combined Gates' technique and captopril test in hypertensive patients (229 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1989; 30(1): 51-56.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
Ferrara LA, Marotta T, Fasano ML, Pasanisi F, Mancini M, Soro S
Relationship Between Characteristics Of Patients And Changes In Blood Pressure During Antihypertensive Treatment (177 visite)
Third European Meeting On Hypertension Milan Italy, 1987; N/D: 168-168.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Mancini M, Pisanti N, Capone D, Fasano ML, Ferrara LA
Salt Intake And Sympathetic Responsiveness In Hypertensive Patients (181 visite)
International Symposium On Nutritional And Metabolic Aspect Of Arterial Hypertension Anacapri, 1985 Apr; N/D: N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Strazzullo P, Ferrara LA, Galletti F, Mancini M, Mastranzo P
Crossover Comparison Of The Antihypertensive And Metabolic Effects Of Muzolimine And The Combination Hydrochlorithiazide-Amiloride (200 visite)
Recent Advances In Diuretic Therapy Andreucci Ve Ed Excerpta Medica, 1983; N/D: 328-334.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
20 Records (15 escludendo Abstract e Conferenze).
Impact factor totale: 46.861 (43.688 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 52.171 (48.988 escludendo Abstract e Conferenze).
Impact factor totale: 46.861 (43.688 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 52.171 (48.988 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Massimiliano Sorbillo on in data Sunday 12 July 2020, 13:15:17
630 views visite. Last view on Ultima visita in data Wednesday 20 January 2021, 18:00:56
ibb.cnr.it